← Eichor
Study identifier: NCT07056569 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters

Condition: Dermatitis, Contact · Dermatitis · Dermatitis, Chronic  ·  Sponsor: Biokosmes Srl

PhaseNA
Planned participants90
Who can joinAll sexes, 6 Months to 65 Years
Healthy volunteersNo

About this study

The study aims to evaluate and confirm the performance of 047 TD Dermatitis cream in the improvement of eczematous dermatitis and contact dermatitis, throughout a reduction in disease severity and symptoms.

This description comes directly from the study's public registry record.

Talk to the study team

Donatella Mariani  ·  +41 79 844 2600  ·  ssu@solarishc.ch

Always discuss trial participation with your own doctor first.

Locations (3)

Studio Medico Pigatto BersaniMilan, ItalyNot Yet Recruiting
Poliambulatorio VeronaVerona, ItalyRecruiting
Studio MedicoVoghera, ItalyNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07056569